Association of HIV-Infection and Antiretroviral Therapy With Levels of Endothelial Progenitor Cells and Subclinical Atherosclerosis

Dulcenombre Gómez‐Garré(Universidad Complutense de Madrid), Arturo Fernández‐Cruz(Hospital Clínico San Carlos), Sergio Serrano‐Villar, Adriana Ortega‐Hernández(Universidad Complutense de Madrid), Manuel Fuentes(Hospital Clínico San Carlos), Teresa Tejerina(Universidad Complutense de Madrid), Paloma Muñoz‐Pacheco(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), M. Camacho Ávila(Hospital Clínico San Carlos), Vicente Estrada(Instituto de Salud Carlos III)
JAIDS Journal of Acquired Immune Deficiency Syndromes
December 15, 2012
10.1097/qai.0b013e31826afbfc
Cited by 22

Related Papers

Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
|JAMA|2016|1.4k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|The Lancet|2006|343